A Problem for Biotech

"Patent trolls" — companies that profit solely by legally enforcing patents they own — are beginning to target the biotech industry, and an August 31 ruling from a US federal court of appeals in Washington, DC, is making it easier for them to do, Nature News' Erika Check Hayden says.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.